tiprankstipranks
Encompass Health (EHC)
NYSE:EHC
US Market
Want to see EHC full AI Analyst Report?

Encompass Health (EHC) Earnings Dates, Call Summary & Reports

455 Followers

Earnings Data

Report Date
Aug 04, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
1.48
Last Year’s EPS
1.4
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented multiple material operating and financial wins: double-digit EBITDA growth, revenue growth, improved clinical quality metrics, lower RN turnover, meaningful decline in premium labor, strong free cash flow and an expanded development pipeline. Offsetting these positives were manageable headwinds: short-term volume impact from unit closures (~85 bps), a one-time increase in bad debt tied to legacy claim write-offs, MA utilization variability, regulatory implementation risk and localized capacity constraints in high-demand markets. Management emphasized plans to address capacity via bed adds, de novos, joint ventures and small-format hospitals, and raised full-year guidance based on Q1 performance. Overall, positives materially outweighed the negatives.
Company Guidance
Encompass Health raised its 2026 guidance, now expecting net operating revenue of $6.375–$6.470 billion, adjusted EBITDA of $1.35–$1.38 billion and adjusted EPS of $5.89–$6.11. The raise follows a strong Q1 (revenue $1.59B, +9%; adjusted EBITDA $348.8M, +11.2%; adjusted free cash flow $194M) driven by 4.3% discharge growth (1.6% same‑store) and a 3.7% increase in net revenue per discharge (bad debt 2.2%, +20 bps). Management reiterated full‑year net pre‑opening/ramp costs of $18–$22M (Q1: $4M), expects net provider tax EBITDA impact roughly flat at ~$21M, and disclosed a growth CapEx midpoint of $725M with a free cash flow midpoint of ~$818M; Q1 share repurchases were ~$71.6M (≈708k shares), dividends were $0.19 per share, and net leverage was 1.9x at quarter end. They also plan to open 7 hospitals (≈340 beds) and add 100–150 beds to existing hospitals in 2026, with a pipeline of 11 hospitals (520 beds) beyond 2026.
Top-Line and Profitability Growth
Q1 revenue increased 9% year-over-year to $1.59 billion; adjusted EBITDA rose 11.2% to $348.8 million. Company raised 2026 guidance to net operating revenue of $6.375B–$6.470B, adjusted EBITDA $1.35B–$1.38B, and adjusted EPS $5.89–$6.11.
Strong Discharge and Pricing Trends
Total discharges grew 4.3% (1.6% same-store), and net revenue per discharge increased 3.7%, driven by patient mix and a favorable Medicare SSI adjustment.
Outstanding Clinical Outcomes and Quality Metrics
Discharge-to-community improved 50 basis points to 84.5%; discharge-to-acute improved 30 bps to 8.6%; discharge-to-SNF improved 20 bps to 6.2% — all above industry averages.
Workforce Stability and Lower Premium Labor
Annualized RN turnover improved to 17.8% from 20.2% (lowest since at least 2012); therapist turnover improved to 6.4% from 7.8%. These improvements helped drive a 9.4% decline in premium labor spend versus Q1 2025 and contract labor FTEs fell to 1.2% of total FTEs (down 10 bps).
Capacity Expansion and Development Pipeline
Opened a new 49-bed hospital in Irmo, SC and added 44 beds to existing hospitals in Q1; plan to open 7 more hospitals (≈340 beds) and add 100–150 incremental beds in 2026. Pipeline beyond 2026: 11 hospitals / 520 beds; developing small-format hospital strategy with at least one expected in 2027.
Strong Cash Generation and Capital Allocation
Q1 adjusted free cash flow of $194 million. Repurchased ~708,000 shares for $71.6 million in Q1; paid and declared $0.19 per share dividends. Net leverage at quarter end was a modest 1.9x, supporting ongoing buybacks and growth CapEx.
Operational Efficiency and Digital/Analytics Initiatives
SWB per FTE increased 3.7%; investments in clinical career ladders and Palantir-enabled market/real-estate, revenue cycle and documentation productivity initiatives expected to drive more efficient clinical and administrative workflows.
Potential Favorable Medicare Pricing Update
CMS 2027 IRF proposed rule included a net market basket update of 2.4%, which the company estimates could yield a ~2.4% pricing increase for Medicare patients beginning Oct 1, 2026 (pending final rule).

Encompass Health (EHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EHC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 04, 2026
2026 (Q2)
1.48 / -
1.4
Apr 30, 2026
2026 (Q1)
1.49 / 1.60
1.3716.79% (+0.23)
Feb 05, 2026
2025 (Q4)
1.30 / 1.46
1.1724.79% (+0.29)
Oct 29, 2025
2025 (Q3)
1.20 / 1.23
1.0319.42% (+0.20)
Aug 04, 2025
2025 (Q2)
1.23 / 1.40
1.1126.13% (+0.29)
Apr 24, 2025
2025 (Q1)
1.19 / 1.37
1.1222.32% (+0.25)
Feb 06, 2025
2024 (Q4)
1.02 / 1.17
0.9523.16% (+0.22)
Oct 28, 2024
2024 (Q3)
0.94 / 1.03
0.8619.77% (+0.17)
Aug 05, 2024
2024 (Q2)
1.01 / 1.11
0.9516.84% (+0.16)
Apr 24, 2024
2024 (Q1)
0.94 / 1.12
0.8827.27% (+0.24)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EHC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$100.00$107.48+7.48%
Feb 05, 2026
$99.36$105.18+5.86%
Oct 29, 2025
$125.16$116.37-7.02%
Aug 04, 2025
$108.93$113.28+4.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Encompass Health (EHC) report earnings?
Encompass Health (EHC) is schdueled to report earning on Aug 04, 2026, After Close (Confirmed).
    What is Encompass Health (EHC) earnings time?
    Encompass Health (EHC) earnings time is at Aug 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EHC EPS forecast?
          EHC EPS forecast for the fiscal quarter 2026 (Q2) is 1.48.